REG - Roadside Real Estate - Exercise of First Tranche of Put Option Agreement

Roadside Real EstateAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe7174Ya&default-theme=true

RNS Number : 7174Y  Roadside Real Estate PLC  31 March 2026

31 March 2026

 

Roadside Real Estate PLC

("Roadside", the "Company" and the "Group")

Exercise of First Tranche of Put Option Agreement

Roadside (AIM: ROAD) confirms that, pursuant to the amended put option
agreement with CGV Ventures 1 Ltd ("CGV") in regard to the sale of the
Company's remaining 48% investment in Cambridge Sleep Sciences ("CSS") -
announced on 9 February 2026 - the put option over the first tranche,
representing 14% of the issued share capital of CSS, has been exercised.

CGV is undertaking the necessary drawdown procedures from its underlying
investors, with the consideration of £14 million expected to be received by
the Company by the end of April 2026.  The Company will complete the
acquisition of D. A. Roberts Fuels Ltd shortly after the receipt of the funds
from CGV.

 

Enquiries:

 Roadside Real Estate PLC

 Steve Carson, Chairman

 Charles Dickson, Chief Executive Officer

 Douglas Benzie, Chief Financial Officer

 c/o Montfort
 Montfort

 Ann-marie Wilkinson                                                     +44 (0)7730 623815

 Alex Everett                                                            +44 (0)7780 431533
 Cavendish Capital Markets Limited (Nomad & Joint Corporate Broker)

 Matt Goode / Seamus Fricker / Elysia Bough (Corporate Finance)

 Matt Lewis / Harriet Ward (ECM)                                         +44 (0) 20 7220 0500
 Shore Capital (Joint Corporate Broker)

 Ben Canning (Corporate Broking)                                         +44 (0)20 7408 4050

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGREAFDEDFFKEAA



            Copyright 2019 Regulatory News Service, all rights reserved